181 related articles for article (PubMed ID: 36198495)
1. A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin.
Holá L; Železná B; Karnošová A; Kuneš J; Fehrentz JA; Denoyelle S; Cantel S; Blechová M; Sýkora D; Myšková A; Maletínská L
J Pharmacol Exp Ther; 2022 Nov; 383(2):129-136. PubMed ID: 36198495
[TBL] [Abstract][Full Text] [Related]
2. Identifying the binding mechanism of LEAP2 to receptor GHSR1a.
Wang JH; Li HZ; Shao XX; Nie WH; Liu YL; Xu ZG; Guo ZY
FEBS J; 2019 Apr; 286(7):1332-1345. PubMed ID: 30666806
[TBL] [Abstract][Full Text] [Related]
3. LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue.
Shankar K; Metzger NP; Singh O; Mani BK; Osborne-Lawrence S; Varshney S; Gupta D; Ogden SB; Takemi S; Richard CP; Nandy K; Liu C; Zigman JM
Mol Metab; 2021 Nov; 53():101327. PubMed ID: 34428557
[TBL] [Abstract][Full Text] [Related]
4. LEAP2 has antagonized the ghrelin receptor GHSR1a since its emergence in ancient fish.
Li HZ; Shou LL; Shao XX; Li N; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2021 Jun; 53(6):939-949. PubMed ID: 33966114
[TBL] [Abstract][Full Text] [Related]
5. LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor.
Ge X; Yang H; Bednarek MA; Galon-Tilleman H; Chen P; Chen M; Lichtman JS; Wang Y; Dalmas O; Yin Y; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
Cell Metab; 2018 Feb; 27(2):461-469.e6. PubMed ID: 29233536
[TBL] [Abstract][Full Text] [Related]
6. Liver-expressed antimicrobial peptide 2 functions independently of growth hormone secretagogue receptor in calorie-restricted mice.
Islam MN; Zhang W; Sakai K; Nakazato Y; Tanida R; Sakoda H; Takei T; Takao T; Nakazato M
Peptides; 2022 May; 151():170763. PubMed ID: 35151767
[TBL] [Abstract][Full Text] [Related]
7. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
M'Kadmi C; Cabral A; Barrile F; Giribaldi J; Cantel S; Damian M; Mary S; Denoyelle S; Dutertre S; Péraldi-Roux S; Neasta J; Oiry C; Banères JL; Marie J; Perello M; Fehrentz JA
J Med Chem; 2019 Jan; 62(2):965-973. PubMed ID: 30543423
[TBL] [Abstract][Full Text] [Related]
8. Liver-Expressed Antimicrobial Peptide 2 antagonizes the insulinostatic effect of ghrelin in rat isolated pancreatic islets.
Bayle M; Péraldi-Roux S; Gautheron G; Cros G; Oiry C; Neasta J
Fundam Clin Pharmacol; 2022 Apr; 36(2):375-377. PubMed ID: 34449915
[TBL] [Abstract][Full Text] [Related]
9. Involvement of POMC neurons in LEAP2 regulation of food intake and body weight.
Chu G; Peng H; Yu N; Zhang Y; Lin X; Lu Y
Front Endocrinol (Lausanne); 2022; 13():932761. PubMed ID: 36387867
[TBL] [Abstract][Full Text] [Related]
10. GHSR controls food deprivation-induced activation of CRF neurons of the hypothalamic paraventricular nucleus in a LEAP2-dependent manner.
Fernandez G; Cabral A; De Francesco PN; Uriarte M; Reynaldo M; Castrogiovanni D; Zubiría G; Giovambattista A; Cantel S; Denoyelle S; Fehrentz JA; Tolle V; Schiöth HB; Perello M
Cell Mol Life Sci; 2022 May; 79(5):277. PubMed ID: 35504998
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model.
Cornejo MP; Castrogiovanni D; Schiöth HB; Reynaldo M; Marie J; Fehrentz JA; Perello M
J Neuroendocrinol; 2019 Oct; 31(10):e12785. PubMed ID: 31469195
[TBL] [Abstract][Full Text] [Related]
12. Identifying key residues and key interactions for the binding of LEAP2 to receptor GHSR1a.
Li HZ; Shou LL; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochem J; 2020 Sep; 477(17):3199-3217. PubMed ID: 32803260
[TBL] [Abstract][Full Text] [Related]
13. Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents.
Islam MN; Mita Y; Maruyama K; Tanida R; Zhang W; Sakoda H; Nakazato M
J Endocrinol; 2020 Jan; 244(1):13-23. PubMed ID: 31539874
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region.
Barrile F; M'Kadmi C; De Francesco PN; Cabral A; García Romero G; Mustafá ER; Cantel S; Damian M; Mary S; Denoyelle S; Banères JL; Marie J; Raingo J; Fehrentz JA; Perelló M
Mol Cell Endocrinol; 2019 Dec; 498():110573. PubMed ID: 31499133
[TBL] [Abstract][Full Text] [Related]
15. Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans.
Englund A; Gilliam-Vigh H; Suppli MP; Gasbjerg LS; Vilsbøll T; Knop FK
Peptides; 2024 Jul; 177():171227. PubMed ID: 38657907
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and analysis of the ghrelin/GHSR system in Xenopus tropicalis.
Wada R; Takemi S; Matsumoto M; Iijima M; Sakai T; Sakata I
Gen Comp Endocrinol; 2023 Jan; 331():114167. PubMed ID: 36402245
[TBL] [Abstract][Full Text] [Related]
17. Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin Receptor.
Deschaine SL; Hedegaard MA; Pince CL; Farokhnia M; Moose JE; Stock IA; Adusumalli S; Akhlaghi F; Hougland JL; Sulima A; Rice KC; Koob GF; Vendruscolo LF; Holst B; Leggio L
J Pharmacol Exp Ther; 2023 Aug; 386(2):117-128. PubMed ID: 36631279
[TBL] [Abstract][Full Text] [Related]
18. High-Fat Diet Induces Resistance to Ghrelin and LEAP2 Peptide Analogs in Mice.
Holá L; Tureckiuová T; Kuneš J; Železná B; Maletínská L
Physiol Res; 2023 Nov; 72(5):607-619. PubMed ID: 38015760
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Characterization of Novel Stable Peptidic Ghrelin Analogs: Beneficial Effects in the Settings of Lipopolysaccharide-Induced Anorexia in Mice.
Holubová M; Blechová M; Kákonová A; Kuneš J; Železná B; Maletínská L
J Pharmacol Exp Ther; 2018 Sep; 366(3):422-432. PubMed ID: 29914876
[TBL] [Abstract][Full Text] [Related]
20. LEAP2 reduces postprandial glucose excursions and
Hagemann CA; Jensen MS; Holm S; Gasbjerg LS; Byberg S; Skov-Jeppesen K; Hartmann B; Holst JJ; Dela F; Vilsbøll T; Christensen MB; Holst B; Knop FK
Cell Rep Med; 2022 Apr; 3(4):100582. PubMed ID: 35492241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
